Literature DB >> 11415949

Sexual factors and the risk of prostate cancer.

K A Rosenblatt1, K G Wicklund, J L Stanford.   

Abstract

A population-based case-control study of prostate cancer was performed in King County, Washington, in White men and Black men aged 40-64 years, between 1993 and 1996. Incident prostate cancer cases (n = 753) were identified from the Seattle-Puget Sound Surveillance, Epidemiology, and End Results (SEER) cancer registry. Controls (n = 703) were identified through random digit dialing and were frequency matched to cases on age. Sexual behavior, medical history, and other potential prostate cancer risk factors were ascertained through an in-person interview. There was no relation between sexual orientation and prostate cancer, although the number of men who had sex with men was small. Risk estimates increased directly with the lifetime number of female sexual partners (trend p < 0.001) but not with male partners (trend p = 0.62). Risk also increased with decreasing age at first intercourse, but this effect disappeared after adjusting for the number of female partners. Prior infection with gonorrhea was positively associated with risk (odds ratio = 1.50; 95% confidence interval: 1.0, 2.2), but no effect was seen among men with other sexually transmitted diseases. No relation between lifetime frequency of sexual intercourse and risk of prostate cancer was apparent. These findings are consistent with previous studies that support an infectious etiology for prostate cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11415949     DOI: 10.1093/aje/153.12.1152

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  40 in total

1.  Sex hormones and the risk of incident prostate cancer.

Authors:  Nicholas A Daniels; Carrie M Nielson; Andrew R Hoffman; Douglas C Bauer
Journal:  Urology       Date:  2010-05-07       Impact factor: 2.649

2.  Association of male circumcision with risk of prostate cancer: a meta-analysis.

Authors:  N Pabalan; E Singian; H Jarjanazi; A Paganini-Hill
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-28       Impact factor: 5.554

3.  Anti-Inflammatory Agents for Cancer Therapy.

Authors:  Elizabeth R Rayburn; Scharri J Ezell; Ruiwen Zhang
Journal:  Mol Cell Pharmacol       Date:  2009

Review 4.  Male circumcision and prostate cancer: A geographical analysis, meta-analysis, and cost analysis.

Authors:  Robert S Van Howe
Journal:  Can Urol Assoc J       Date:  2020-07       Impact factor: 1.862

5.  Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study.

Authors:  D M Moreira; J C Nickel; G L Andriole; R Castro-Santamaria; S J Freedland
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-19       Impact factor: 5.554

6.  Exploring prostate cancer literacy and family cancer awareness in college students: getting ahead of the curve in cancer education.

Authors:  Lisa C Campbell; Jasmyne McClain
Journal:  J Cancer Educ       Date:  2013-12       Impact factor: 2.037

Review 7.  Inflammation and prostate cancer: a focus on infections.

Authors:  Siobhan Sutcliffe; Elizabeth A Platz
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

8.  Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assay.

Authors:  Oleg A Alexeyev; Ingrid Marklund; Beverley Shannon; Irina Golovleva; Jan Olsson; Charlotte Andersson; Irene Eriksson; Ronald Cohen; Fredrik Elgh
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

9.  Antibiotic and anti-inflammatory use and the risk of prostate cancer.

Authors:  Nicholas A Daniels; Yea-Hung Chen; Stephen Bent
Journal:  BMC Res Notes       Date:  2009-04-17

10.  Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study.

Authors:  Iona Cheng; John S Witte; Steven J Jacobsen; Reina Haque; Virginia P Quinn; Charles P Quesenberry; Bette J Caan; Stephen K Van Den Eeden
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.